Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

STATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER

NPI: 1558798603 · GRENADA, MS 38901 · General Acute Care Hospital · NPI assigned 10/03/2013

$17.82M
Total Medicaid Paid
615,000
Total Claims
463,911
Beneficiaries
261
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCOOK, KEVIN (CEO)
Parent OrganizationSTATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
NPI Enumeration Date10/03/2013

Related Entities

Other providers sharing the same authorized official: COOK, KEVIN

ProviderCityStateTotal Paid
STATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER GRENADA MS $2.03M
STATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER GRENADA MS $163K
STATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER GRENADA MS $39K
STATE OF MISSISSIPPI-UNIVERSITY OF MISSISSIPPI MEDICAL CENTER GRENADA MS $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 85,118 $2.66M
2019 80,520 $2.73M
2020 73,134 $2.15M
2021 83,777 $2.36M
2022 101,109 $2.59M
2023 108,167 $2.94M
2024 83,175 $2.40M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 19,590 16,166 $2.32M
99284 Emergency department visit for the evaluation and management, high severity 13,881 11,560 $2.26M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 6,124 5,050 $1.14M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 8,835 7,069 $815K
G0378 Hospital observation service, per hour 3,029 2,303 $692K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,774 4,984 $474K
99281 Emergency department visit for the evaluation and management, self-limited or minor 10,872 9,046 $453K
86885 5,121 3,993 $368K
71045 Radiologic examination, chest; single view 10,810 8,862 $362K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,526 2,206 $338K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 8,808 7,001 $338K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 13,492 2,456 $336K
86900 5,575 4,300 $295K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 11,226 8,681 $278K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 11,234 8,687 $272K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,626 2,230 $263K
71046 Radiologic examination, chest; 2 views 6,860 5,843 $257K
81513 2,773 2,212 $227K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,500 1,791 $222K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 42,313 31,681 $206K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,198 2,870 $189K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 2,624 2,211 $180K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 9,233 7,635 $177K
70450 Computed tomography, head or brain; without contrast material 4,114 3,504 $173K
80053 Comprehensive metabolic panel 24,334 18,610 $159K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,677 825 $154K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 11,604 5,575 $148K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 6,992 5,220 $142K
87428 2,665 2,327 $139K
96361 Intravenous infusion, hydration; each additional hour 4,663 3,752 $139K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2,196 2,004 $137K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 833 743 $129K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 7,751 6,366 $127K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,692 1,511 $123K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 4,480 1,080 $118K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,935 1,588 $112K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 1,399 1,243 $107K
96375 Therapeutic injection; each additional sequential IV push 4,525 3,627 $104K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,240 2,663 $100K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1,122 918 $97K
74018 2,425 2,026 $96K
97530 Therapeutic activities, direct patient contact, each 15 minutes 4,755 1,285 $95K
86901 5,562 4,300 $91K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 788 507 $90K
A0425 Ground mileage, per statute mile 1,093 649 $88K
80074 2,658 2,204 $82K
36415 Collection of venous blood by venipuncture 30,589 22,884 $79K
77067 Screening mammography, bilateral, including computer-aided detection 945 886 $70K
80306 6,068 4,918 $70K
80048 Basic metabolic panel (calcium, ionized) 12,757 10,255 $69K
76801 1,069 886 $69K
87481 3,016 2,413 $68K
84443 Thyroid stimulating hormone (TSH) 5,982 5,185 $66K
11043 474 214 $64K
87070 9,004 7,821 $63K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,427 3,115 $62K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4,978 4,256 $60K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 807 586 $55K
72100 1,135 1,021 $55K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 185 172 $51K
83880 2,993 2,359 $50K
73030 1,457 1,264 $45K
87086 Culture, bacterial; quantitative colony count, urine 8,131 6,748 $44K
84702 4,149 2,808 $44K
84484 7,562 5,075 $44K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 827 703 $42K
73630 1,066 911 $41K
59025 Fetal non-stress test 421 210 $38K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,851 610 $37K
80061 Lipid panel 4,008 3,530 $36K
81025 6,344 5,107 $36K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,946 1,690 $35K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 160 129 $34K
73610 762 641 $32K
83036 Hemoglobin; glycosylated (A1C) 5,173 4,535 $31K
83021 2,353 1,952 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 705 620 $30K
76830 Ultrasound, transvaginal 515 437 $30K
81001 13,474 10,834 $30K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,949 1,163 $28K
86762 2,715 2,249 $28K
87077 4,849 3,597 $26K
73130 634 532 $26K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 413 375 $26K
87040 4,780 2,713 $25K
86780 2,861 2,280 $25K
86787 2,800 2,211 $25K
87186 4,070 3,027 $24K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,027 567 $23K
76642 669 550 $23K
82947 9,848 5,464 $23K
86696 1,605 1,335 $22K
87807 1,864 1,645 $20K
83735 5,980 4,397 $20K
73502 708 637 $18K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2,199 551 $18K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1,001 841 $17K
73562 515 457 $17K
86592 5,352 4,531 $17K
76770 361 305 $16K
59050 475 381 $16K
83690 4,337 3,486 $16K
86695 1,611 1,338 $15K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 175 157 $15K
73560 473 382 $14K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 490 321 $13K
87660 1,055 873 $13K
87480 1,055 873 $13K
83605 2,667 2,121 $13K
87510 1,055 873 $13K
76819 Fetal biophysical profile; without non-stress testing 142 86 $12K
97016 1,955 423 $12K
86140 3,129 2,537 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 522 431 $11K
36902 15 12 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material 150 136 $11K
97014 1,289 323 $10K
72125 Computed tomography, cervical spine; without contrast material 333 277 $10K
85027 2,284 1,855 $10K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 84 75 $10K
87340 1,203 1,019 $9K
97161 254 214 $9K
85610 4,131 3,327 $9K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 27 26 $9K
84153 989 853 $9K
87081 1,679 1,498 $9K
85730 2,678 2,229 $9K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 626 499 $8K
97162 227 179 $8K
81003 4,958 4,144 $8K
93925 110 101 $8K
82550 1,926 1,505 $7K
77066 Tomosynthesis, mammo 105 101 $7K
93971 210 195 $7K
81243 1,136 931 $7K
82248 1,801 1,430 $6K
36430 68 50 $6K
87563 281 166 $6K
87486 185 172 $6K
87581 185 172 $6K
84439 922 814 $6K
86694 516 396 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 177 114 $5K
72040 150 128 $5K
87205 1,540 1,301 $5K
73564 82 74 $5K
77065 Tomosynthesis, mammo 87 78 $5K
85379 872 703 $4K
93970 74 72 $4K
82105 367 323 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,588 3,937 $4K
J0561 Injection, penicillin g benzathine, 100,000 units 37 30 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited 66 61 $4K
71250 108 93 $4K
71275 Computed tomographic angiography, chest, with contrast material 71 68 $4K
73110 110 89 $4K
97165 83 68 $4K
76000 50 41 $4K
87536 62 43 $3K
84550 1,203 960 $3K
J7030 Infusion, normal saline solution , 1000 cc 1,759 758 $3K
84703 468 382 $3K
92523 18 15 $2K
85652 1,335 1,082 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 20 17 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 84 73 $2K
73590 57 41 $2K
83615 435 317 $2K
87430 122 119 $2K
82570 484 389 $2K
82150 420 361 $2K
87420 127 123 $2K
A6196 Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing 306 177 $1K
82553 178 122 $1K
84100 708 487 $1K
0202U Oncology (prostate), multianalyte, gene expression profiling 372 322 $1K
36600 31 25 $1K
80197 211 137 $1K
84156 483 390 $1K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 63 55 $1K
P9016 Red blood cells, leukocytes reduced, each unit 14 12 $958.73
94762 39 30 $917.12
82607 113 98 $887.88
76536 17 12 $873.32
11045 382 187 $811.58
82803 65 38 $747.65
83540 175 153 $710.41
73090 16 13 $605.03
80143 74 51 $566.77
83550 88 81 $560.79
80179 74 50 $539.33
82728 69 64 $514.15
72170 13 12 $491.36
A0429 Ambulance service, basic life support, emergency transport (bls-emergency) 122 108 $460.60
73620 12 12 $367.22
85660 97 78 $365.67
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,828 2,978 $340.62
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,951 4,099 $325.97
C9113 Injection, pantoprazole sodium, per vial 1,196 825 $321.84
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 24 12 $219.80
87899 24 15 $218.03
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 2,693 2,026 $185.40
84134 13 12 $175.68
82247 37 25 $172.31
80069 25 25 $165.82
87046 19 16 $152.53
87045 18 16 $152.53
82565 55 52 $140.57
85045 48 26 $130.72
81015 73 68 $125.86
84403 13 12 $116.38
84460 29 29 $104.94
J1885 Injection, ketorolac tromethamine, per 15 mg 4,387 3,478 $100.52
84450 29 29 $90.22
82465 31 26 $89.98
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 18 13 $81.67
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 268 190 $81.32
82800 13 13 $49.60
87210 14 12 $47.37
82043 15 13 $46.38
J3010 Injection, fentanyl citrate, 0.1 mg 3,708 2,879 $35.21
82270 18 13 $28.48
J2250 Injection, midazolam hydrochloride, per 1 mg 2,680 2,158 $15.00
J2270 Injection, morphine sulfate, up to 10 mg 1,857 1,301 $8.89
77063 Screening digital breast tomosynthesis, bilateral 15 14 $6.20
J0131 Injection, acetaminophen, not otherwise specified,10 mg 989 763 $0.00
J1170 Injection, hydromorphone, up to 4 mg 1,728 1,115 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 846 565 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 240 205 $0.00
C1893 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away 97 83 $0.00
77001 500 412 $0.00
36416 178 153 $0.00
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) 34 27 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 74 51 $0.00
A0428 Ambulance service, basic life support, non-emergency transport, (bls) 130 51 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 15 12 $0.00
96376 172 148 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 96 80 $0.00
J1815 Injection, insulin, per 5 units 50 31 $0.00
C1769 Guide wire 18 14 $0.00
J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg 14 13 $0.00
90715 60 54 $0.00
84145 614 522 $0.00
81401 534 439 $0.00
76937 580 475 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 148 147 $0.00
J3370 Injection, vancomycin hcl, 500 mg 204 152 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 230 196 $0.00
J7510 Prednisolone oral, per 5 mg 109 88 $0.00
C1765 Adhesion barrier 58 56 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 74 55 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 153 99 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 21 15 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 208 106 $0.00
Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml 230 194 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 39 26 $0.00
J1956 Injection, levofloxacin, 250 mg 21 14 $0.00
J1756 Injection, iron sucrose, 1 mg 33 12 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 17 14 $0.00
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 21 15 $0.00
C1776 Joint device (implantable) 15 13 $0.00